Paul Hudson, Sanofi CEO (via Getty)

Fol­low­ing $1.9B buy­out, Sanofi shut­ters Kad­mon's NY site and chops 25 staffers

Sanofi CEO Paul Hud­son is on a mis­sion to re­shape the com­pa­ny. Last year, that in­volved shelling out $1.9 bil­lion for Kad­mon and its new­ly ap­proved Rezurock — but ap­par­ent­ly, the for­mer biotech’s New York site is not part of Hud­son’s vi­sion.

The phar­ma gi­ant is shut­ting down Kad­mon’s New York plant in Q3 and lay­ing off 25 em­ploy­ees, ac­cord­ing to New York state doc­u­ments. The lay­offs will be­gin Ju­ly 1, and con­tin­ue through April 1, 2023.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.